Compare HCA Health Inc (HCA) vs Yum China Holdings Inc (YUMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Yum China Holdings Inc — how do they compare? HCA Health Inc trades at $446.39 (market cap $96.35B), while Yum China Holdings Inc trades at $42.98 (market cap $14.11B). The key difference: HCA Health Inc is far larger — about 6.8× Yum China Holdings Inc's market cap, and Yum China Holdings Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Yum China Holdings Inc for 77 Days on average.
| HCA | YUMC | |
|---|---|---|
Market Cap | $96.35B | $14.11B |
Volume | 1,079,453 | 2,350,650 |
Sector | Health | Consumer Cyclical |
52-Week High | $545.13 | $57.95 |
52-Week Low | $361.32 | $39.98 |
Typical Hold Time | 76 Days | 77 Days |
Enterprise Value | $146.88B | $15.02B |
Dividend Yield | 0.7% | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $439.17, up 1.61% today, with a bullish technical signal and strong fundamental performance. Revenue grew to $75.6 billion in 2025, with net income reaching $6.78 billion, and the company has beaten EPS estimates for three consecutive quarters. Recent news includes an upcoming Q3 2026 earnings call and the completion of the College of Health Care Professions acquisition, highlighting operational expansion.
The outlook remains positive with a consensus price target of $461.12, though risks include ongoing legal investigations and high debt levels. Earnings growth and cost controls support upside potential, but investors should monitor regulatory developments and payer-mix pressures that could impact margins.
YUMC trades at $40.65 with minimal daily movement (+0.07%). The stock shows strong fundamental performance with consistent earnings beats (Q4 2025-Q2 2026) and solid profitability metrics (ROE 17.5%, net margin 7.84%). Recent business developments include the acquisition of Pizza Hut brand ownership in mainland China and expansion of Pizza Hut Burger Bar to 300 locations. Technical indicators show bearish momentum with the stock trading near key support at $40.
YUMC presents a compelling value opportunity with reasonable valuation multiples (P/E 15.3, P/S 1.2) and strong analyst support (73.68% buy ratings). Upside potential exists from continued store expansion and brand innovation, though investors should monitor China's consumer spending trends and competitive pressures in the restaurant sector. The stock's current technical weakness may offer entry points for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Yum China Holdings Inc
With almost 10,600 units and USD 9.5 billion in systemwide sales in 2020, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (7,166 units) and Pizza Hut (2,355), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 985 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.
Read more on YUMC →
